MedinCell 過去の業績
過去 基準チェック /06
MedinCell's earnings have been declining at an average annual rate of -13.9%, while the Pharmaceuticals industry saw earnings growing at 8.5% annually. Revenues have been growing at an average rate of 11.9% per year.
主要情報
-13.9%
収益成長率
-3.1%
EPS成長率
| Pharmaceuticals 業界の成長 | 6.0% |
| 収益成長率 | 11.9% |
| 株主資本利益率 | n/a |
| ネット・マージン | -234.4% |
| 次回の業績アップデート | 06 Dec 2023 |
最近の業績更新
更新なし
Recent updates
収支内訳
MedinCell の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 31 Mar 23 | 14 | -32 | 10 | 28 |
| 31 Dec 22 | 13 | -29 | 9 | 28 |
| 30 Sep 22 | 8 | -27 | 9 | 27 |
| 30 Jun 22 | 6 | -26 | 9 | 25 |
| 31 Mar 22 | 8 | -25 | 8 | 24 |
| 31 Dec 21 | 9 | -22 | 8 | 23 |
| 30 Sep 21 | 9 | -20 | 8 | 23 |
| 30 Jun 21 | 9 | -19 | 8 | 21 |
| 31 Mar 21 | 8 | -19 | 7 | 20 |
| 31 Dec 20 | 7 | -22 | 7 | 18 |
| 30 Sep 20 | 5 | -26 | 8 | 17 |
| 30 Jun 20 | 6 | -25 | 8 | 17 |
| 31 Mar 20 | 6 | -24 | 8 | 17 |
| 31 Dec 19 | 6 | -21 | 8 | 16 |
| 30 Sep 19 | 6 | -19 | 8 | 15 |
| 30 Jun 19 | 5 | -19 | 8 | 13 |
| 31 Mar 19 | 4 | -20 | 8 | 12 |
| 31 Dec 18 | 6 | -17 | 7 | 11 |
| 30 Sep 18 | 7 | -15 | 7 | 10 |
| 30 Jun 18 | 8 | -12 | 6 | 9 |
| 31 Mar 18 | 8 | -10 | 6 | 9 |
| 31 Mar 17 | 10 | -4 | 4 | 8 |
| 31 Mar 16 | 9 | 1 | 3 | 6 |
質の高い収益: MDCL.F is currently unprofitable.
利益率の向上: MDCL.F is currently unprofitable.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: MDCL.F is unprofitable, and losses have increased over the past 5 years at a rate of 13.9% per year.
成長の加速: Unable to compare MDCL.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
収益対業界: MDCL.F is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-17.3%).
株主資本利益率
高いROE: MDCL.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.